Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2020 · 10-Q
Revenue$9.40M$9.40M+66.8% vs Q2 2019 Net Income$14.88M$14.88MN/M vs Q2 2019 EPS Diluted$0.40$0.40— vs Q2 2019 Gross Profit$6,666,960+88.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,273,508N/M Free Cash Flowderived-$5,514,180N/M Margins · derivedGross margin70.9%+8.2 pt vs Q2 2019
Operating margin-59.6%+524.5 pt vs Q2 2019
Net margin158.4%+723.4 pt vs Q2 2019
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end